plerixafor has been researched along with Cancer of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assanelli, A; Bellio, L; Ciceri, F; Coppola, M; Corti, C; De Freitas, T; Gattillo, S; Malabarba, L; Malato, S; Marktel, S; Milani, R; Rizzo, L | 1 |
1 trial(s) available for plerixafor and Cancer of Kidney
| Article | Year |
|---|---|
Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation.
Topics: Adult; Aged; Allografts; Antigens, CD34; Benzylamines; Blood Cell Count; Carcinoma, Renal Cell; Colony-Forming Units Assay; Cyclams; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Kidney Neoplasms; Lenograstim; Leukapheresis; Leukemia, Myeloid, Acute; Living Donors; Male; Middle Aged; Pain; Parents; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Siblings; Treatment Outcome | 2015 |